Literature DB >> 5443056

Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate.

D R Mishell, M Talas, A F Parlow, D L Moyer.   

Abstract

Entities:  

Keywords:  Biology; Body Temperature; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Endocrine System; Family Planning; Gonadotropins; Gonadotropins, Pituitary; Hormones; Luteinizing Hormone--analysis; Medroxyprogesterone Acetate; Physiology; Research Methodology; Silastic Ring

Mesh：

Substances：

Year:  1970        PMID： 5443056     DOI： 10.1016/s0002-9378(16)33897-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  10 in total

1.  Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring.

Authors:  C J Timmer; T M Mulders
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

2.  Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections.

Authors:  David R Friend
Journal:  Drug Deliv Transl Res       Date:  2011-06       Impact factor: 4.617

Review 3.  Controlled-release delivery systems for hormones. A review of their properties and current therapeutic use.

Authors:  L R Beck; V Z Pope
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

Review 4.  Vaginal rings for menopausal symptom relief.

Authors:  Susan A Ballagh
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.

Authors:  Todd J Johnson; Meredith R Clark; Theodore H Albright; Joel S Nebeker; Anthony L Tuitupou; Justin T Clark; Judit Fabian; R Tyler McCabe; Neelima Chandra; Gustavo F Doncel; David R Friend; Patrick F Kiser
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

6.  A UPLC-MS/MS method for therapeutic drug monitoring of etonogestrel.

Authors:  Tiffany Thomas; Kelsey Petrie; Joonho Shim; Kirsten M Abildskov; Carolyn L Westhoff; Serge Cremers
Journal:  Ther Drug Monit       Date:  2013-12       Impact factor: 3.681

Review 7.  Mesenteric vein thrombosis associated with intravaginal contraceptives: a case report and review of the literature.

Authors:  Deepak Voora; Anitha Vijayan
Journal:  J Thromb Thrombolysis       Date:  2003-04       Impact factor: 2.300

Review 8.  Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.

Authors:  Andrea Ries Thurman; Meredith R Clark; Jennifer A Hurlburt; Gustavo F Doncel
Journal:  Int J Womens Health       Date:  2013-10-21

9.  Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES.

Authors:  John W McBride; Peter Boyd; Nicola Dias; David Cameron; Robin E Offord; Oliver Hartley; Vicky L Kett; R Karl Malcolm
Journal:  J Control Release       Date:  2019-02-04       Impact factor: 9.776

10.  Development of an intravaginal ring delivering simultaneously anastrozole and levonorgestrel: a pharmacokinetic perspective.

Authors:  Rüdiger Nave
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.